Paradigm Biopharmaceuticals Ltd Investor Webinar Transcript
Thank you for standing by, and welcome to the Paradigm Biopharmaceuticals investor webinar today, discussing the capital raising being undertaken by the company. (Operator Instructions) Appearing on behalf of Paradigm today, we have the Chairman, Paul Rennie; CEO, Marco Polizzi; Chief Medical Officer, Dr. Donna Skerrett; and Director of Investor Relations, Simon White.
To begin, I'll hand it over to Paul. Please go ahead.
Thank you, Matt. And just by way of introduction, I was asked to say a few words in relation to the capital raise. But before I present the details of the capital raise, could I just maybe position the capital raise with a few comments.
So we put this capital raise within context for our investors. So some people may think, why wouldn't we raise capital now? And as a lot of investors know, at our last quarterly webinar, we announced that we had four quarters of cash. So by definition, at the end of the next quarter, which will be the October report, it's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |